King-Devick technologies, inc. offers a broad set of evidence-based solutions utilizing integrated technology for concussion sideline screening, reading performance, and as indicators of neurological function.
King-Devick products have been scientifically validated in more than 120 recent peer reviewed articles published in elite medical journals related to concussion management, reading solutions, migraines, Alzheimer’s disease, hypoxia, multiple sclerosis, Parkinson’s disease, extreme sleep deprivation and ALS.
King-Devick Test in association
with Mayo Clinic
In an effort to bring awareness and increase concussion screening, in 2015, Mayo Clinic and King-Devick technologies, inc. announced that they had executed a licensing agreement to co-brand the King-Devick concussion screening test to King-Devick Test in association with Mayo Clinic. Read the complete press release here.
In 2017, global learning company Houghton Mifflin Harcourt partnered with King-Devick technologies, inc. to bring the King-Devick Reading Acceleration Program, a new proven-effective approach to strengthening literacy skills by teaching the physical act of reading, to students in elementary classrooms. Read the complete press release here.